William P. Burke
Net Worth
Last updated:
What is William P. Burke net worth?
The estimated net worth of Mr. William P. Burke is at least $22,653,817 as of 23 Aug 2021. He owns shares worth $1,618,751 as insider, has earned $13,628,186 from insider trading and has received compensation worth at least $7,406,880 in Haemonetics Corporation.
What is the salary of William P. Burke?
Mr. William P. Burke salary is $925,860 per year as Chief Financial Officer & Executive Vice President in Haemonetics Corporation.
How old is William P. Burke?
Mr. William P. Burke is 57 years old, born in 1968.
What stocks does William P. Burke currently own?
As insider, Mr. William P. Burke owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Haemonetics Corporation (HAE) | Chief Financial Officer & Executive Vice President | 30,291 | $53.44 | $1,618,751 |
What does Haemonetics Corporation do?
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.
William P. Burke insider trading
Haemonetics Corporation
Mr. William P. Burke has made 26 insider trades between 2017-2021, according to the Form 4 filled with the SEC. Most recently he sold 22,667 units of HAE stock worth $1,371,580 on 23 Aug 2021.
The largest trade he's ever made was exercising 22,704 units of HAE stock on 9 Oct 2019. As of 23 Aug 2021 he still owns at least 30,291 units of HAE stock.
Haemonetics key executives
Haemonetics Corporation executives and other stock owners filed with the SEC:
- Mr. Christopher A. Simon (61) Chief Executive Officer, Pres & Director
- Mr. Josep Lluis Llorens (63) Senior Vice President of Global Manufacturing & Supply Chain
- Mr. William P. Burke (57) Chief Financial Officer & Executive Vice President
- Ms. Anila Lingamneni (58) Executive Vice President & Chief Technology Officer
- Ms. Michelle L. Basil (53) Executive Vice President, Gen. Counsel & Sec.